School of Medicine
Showing 101-150 of 2,421 Results
-
Muriel Babey
Assistant Professor of Medicine (Endocrinology)
BioMuriel Babey, M.D. is an Assistant Professor of Medicine in the Division of Endocrinology, Gerontology & Metabolism at Stanford University. She is a physician–scientist who specializes in metabolic bone disease and osteoporosis, with a focus on skeletal health during reproductive transitions and aging, as well as disorders of calcium and parathyroid metabolism.
Originally from Switzerland, Dr. Babey earned her medical degree in Switzerland and completed fellowship training in Endocrinology at the University of California, San Francisco. During her postdoctoral training in the laboratory of Holly Ingraham at UCSF, her work focused on identifying CCN3 as a maternal brain–derived osteoanabolic hormone critical for lactation, uncovering a previously unrecognized neuroendocrine axis regulating bone formation and marrow adiposity.
Dr. Babey directs a research program that integrates human cohort studies with mechanistic models to define endocrine pathways coordinating skeletal and metabolic resilience across reproductive transitions and aging. Her work centers on identifying secreted factors and interorgan communication networks that regulate bone health, with the goal of advancing translational strategies for osteoporosis and related metabolic diseases. Her research is supported by an NIH K08 award, and she is a recipient of the Endocrine Society Early Investigator Award and the ASBMR John Haddad Early Investigator Award. -
Christopher Sam Babu
Clinical Assistant Professor, Medicine
BioChristopher Babu, MD is a Clinical Assistant Professor in the Division of Hospital Medicine and Stanford School of Medicine. He received his medical degree from Weil Cornell Medicine and completed his residency in Internal Medicine at Stanford. His primary clinical role is as a cardiovascular (CV) hospitalist and his research interests pertain to cardio-metabolic health, addressing healthcare disparities and preventive cardiology. He is passionate about medical education and completed clinical pathways in Medical Education and Clinical Research during residency.
-
Florian Bach
Postdoctoral Scholar, Infectious Diseases
BioI'm a molecular infection biologist by training, but shifted my focus from pathogens to hosts for my graduate research. During my PhD with Phil Spence in Edinburgh I studied both falciparum and vivax malaria using controlled human (re)infection models, collaborating closely with the groups of Simon Draper and Angela Minassian in Oxford. As a hybrid bioinformatician and experimentalist, I love systems immunology for answering complex questions about human health. For my postdoc, I study in how the human immune response to malaria evolves in infants as they become reinfected and age. I'm also interested in how such early-life immunological events, malaria and beyond, may affect vaccine responses and immune development later in life. I address this question by making use of a longitudinal study cohort of infants receiving monthly chemoprevention in Eastern Uganda, together with our collaborators at UC San Francisco and IDRC Uganda. More recently, I founded the Early Life Immunology in Africa (ELIA) consortium to pool and synergize clinical, proteomics and metagenomics datasets across multiple birth cohorts across Africa.I am a Global Health Postdoctoral Affiliate with the Stanford Center for Innovation in Global Health.
-
Adrian Matias Bacong
Affiliate, Medicine - Med/Family and Community Medicine
BioAdrian Matias Bacong, PhD, MPH is a postdoctoral research scholar within the Stanford University School of Medicine - Division of Cardiovascular Medicine. His current projects evaluate the utility of racial correction factors in cardiovascular risk algorithms, such as pooled cohort equations. This project is funded through the American Heart Association. His research also explores the intersections of social factors on health, especially among Asian Americans.
His work has been published in the Journal of Epidemiology and Community Health, Journal of Health and Social Behavior, Social Science and Medicine, the Journal of the American Heart Association, and the Journal of the American Medical Association. Dr. Bacong graduated with this PhD in Community Health Sciences from the UCLA Fielding School of Public Health in 2022 and received his MPH in Health Promotion and Behavioral Science from the San Diego State University School of Public Health in 2016. -
Cameron Scott Bader
Postdoctoral Scholar, Bone Marrow Transplantation
BioMy research is focused on using preclinical models to develop novel therapies which improve outcomes for patients receiving allogeneic hematopoietic stem cell transplantation. Currently, my work aims to establish strategies to reduce the risk of relapse after allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease or interfering with donor stem cell engraftment.
-
Adi badhwar
Affiliate, Computational Medicine
BioBuilding healthcare technology products powered by deep-learning & big data from concept to scale
-
Nitish Badhwar
Clinical Professor, Medicine - Cardiovascular Medicine
BioNitish Badhwar, MD is Professor of Medicine and Director of Cardiac Electrophysiology Training Program at Stanford University School of Medicine. Dr. Badhwar received his medical degree from Maulana Azad Medical College (University of Delhi, India). After completing his internal medicine training from New York Hospital of Queens (affiliated with Cornell Medical School), he worked as faculty in the Department of Medicine at Hospital of St. Raphael (Yale University School of Medicine). He completed Cardiac Electrophysiology training at UCSF with Dr. Scheinman. After being on faculty at UCSF for 15 years he recently joined the Arrhythmia Service at Stanford Hospital. He is a Fellow of American College of Cardiology and Heart Rhythm Society. He has been named best doctor in cardiac electrophysiology in San Francisco Magazine since 2015 (2015-2025). This is nominated by his peers. He is the recipient of Excellence in Teaching award by UCSF Academy of Medical Educators in 2015, ACC Distinguished Teacher Award in 2024 and Heart Rhythm Society Distinguished Teacher Award in 2026. He is an invited speaker at prestigious international meetings including Oriental Congress of Cardiology (OCC) in Shanghai, China; Cardiostim EHRA /Europace in Nice, France; Asia Pacific Heart Rhythm Society (APHRS) in Seoul, S Korea; American Heart Association Annual Scientific Session in New Orleans, LA and Indian Heart Rhythm Society in New Delhi, India.
Clinical Interest: Dr. Badhwar's clinical interest is in complex catheter ablation procedures including mapping and ventricular tachycardia (VT), atrial fibrillation (AF) and supraventricular tachycardia (SVT) including junctional variants of SVT. He started the epicardial ablation program at UCSF and also worked with Dr. Randall Lee to perform the first percutaneous epicardial left atrial appendage (LAA) ligation in the Bay Area in patients with atrial fibrillation. He has also differentiated himself in the field of electrophysiology by performing hybrid procedures with CT surgeons in patients with AF and VT. He is also involved in device implantation including pacemakers, ICD and biventricular pacing for heart failure.
Research Interest: Dr. Badhwar has published electrophysiologic characteristics of SVTs including atrial tachycardia arising from the coronary sinus musculature, para-hisian atrial tachycardia, left sided AVNRT, junctional tachycardia and nodofascicular tachycardia. He has also published on the use of nuclear medicine (ERNA) in assessing left ventricular dyssynchrony as well as optimal pacing sties in patients with heart failure requiring biventricular pacing. He has described the unique clinical characteristics of epicardial idiopathic VT arising from the cardiac crux and septal fascicular VT. He has also published clinical outcomes of combining LAA ligation with catheter ablation of atrial fibrillation (first in human percutaneous closed chested Maze procedure) and participated in multi-center randomized trials of hybrid AF ablation ( DEEP trial and aMAZE trial). He was part of the VINTAGE project that used novel technique for ablation of intramural deep septal VT. -
Jehan Bahrainwala, MD, FASN
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Bahrainwala is a board-certified, fellowship-trained nephrologist with the Stanford Medicine Kidney Clinic. She is a Certified Hypertension Specialist practicing at the AHA-Certified Stanford Hypertension Center. One of her main clinical areas of focus is the diagnosis and treatment of resistant hypertension and secondary hypertension. She also has a clinical interest in caring for patients who are pregnant or planning pregnancy with hypertension and kidney disease. In addition to hypertension, she also cares for patients with all types of kidney diseases. Her extensive experience includes caring for patients with electrolyte abnormalities, kidney stones, chronic kidney disease and end stage kidney disease.
Dr. Bahrainwala is skilled at creating connections with her patients. She treats the whole person rather than the condition. She also strongly believes in patient education and involving them in the medical decision-making process. She integrates their goals of care and other aspects of advanced care planning into treatment planning. She is also interested in the conservative care of elderly patients with advanced kidney disease. She has formal communication skills training in discussing serious illnesses with patients through Vital Talk.
In addition to being a clinician, she is committed to and involved in the medical education of trainees at all levels including medical students, residents and fellows. She is a fellow and a member of the American Society of Nephrology. Additionally, she is a member of the National Kidney Foundation and the American Heart Association. She is double board certified in internal medicine and nephrology. -
Xiangqi Bai
Postdoctoral Scholar, Oncology
BioMy research is focused on computational and systems biology. My primary research interest lies in developing new computational algorithms and statistical methods for the analysis of complex data in biological systems, especially related to the large-scale single-cell RNA sequencing data. The specific topics I have examined include:
1. Integration of single-cell multi-omics datasets for tumor
2. Statistical test of cell developmental trajectories
3. Visualization and reconstruction of single-cell RNA sequencing data
4. Computational analysis of the bifurcating event revealed by dynamical network biomarker methods -
Gali Bai
Postdoctoral Scholar, Oncology
BioI'm a computational biologist training toward a career at the intersection of genomics and cancer biology. I completed my Ph.D. in Bioinformatics at UC Santa Cruz, where I built deep learning models linking chromatin structure to RNA processing using long-read sequencing data. I like breaking down complex biomedical problems into small, tractable engineering questions, and I'm especially motivated by building tools that help clinicians move toward personalized cancer therapy. Outside of work, I love grocery shopping and cooking.
-
Michael Baiocchi
Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.
Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives. -
Matthew C. Baker, MD MS
Associate Professor of Medicine (Immunology and Rheumatology)
BioDr. Baker is an Associate Professor of Medicine and Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University. He is an internationally recognized expert in IgG4-related disease and is the Co-Founder and Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. Dr. Baker received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and a master's degree in Epidemiology and Clinical Research from Stanford University. He completed his residency in Internal Medicine at Massachusetts General Hospital and his fellowship in Rheumatology at Stanford University.
Dr. Baker's research program spans clinical trials, epidemiology, and translational science with the goal of accelerating the development of innovative therapies for immune-mediated diseases. He has designed and led investigator-initiated and industry-sponsored clinical trials in IgG4-related disease, sarcoidosis, Sjögren's disease, and rheumatoid arthritis. His epidemiologic research focuses on defining disease mechanisms, identifying novel therapeutic targets, and repurposing existing medications, including for the treatment of osteoarthritis.
Dr. Baker is also the Co-Founder and Co-Director of the Stanford Immune Reset Program, an interdisciplinary initiative dedicated to advancing transformative therapies with curative potential for autoimmune diseases, including T-cell engagers and in vivo CAR T-cell therapies. -
Niaz Banaei
Professor of Pathology and of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsHis research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.
-
Subhas Banerjee
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Banerjee is the Director of Endoscopy at the Stanford University Medical Center. His research interests include evaluation of advanced endoscopic procedures (ERCP, choledochoscopy and endoscopic ultrasound) in the diagnosis and management of benign and malignant pancreatic and biliary disease. Additional interests include the development of new endoscopic devices and instruments.
-
Narges Baniasadi
Academic Staff - Hourly - CSL, Medicine - Stanford Prevention Research Center
BioDr. Narges Baniasadi is founder and executive director of Emergence program at Stanford. She develops educational and translational programs for improving societal health through entrepreneurship. She is also Adjunct Professor with the Department of Medicine where she teaches impact entrepreneurship in the areas related to Prevention and Health Equity. Narges has led multiple initiatives and businesses in the intersection of Technology and Life Sciences for more than a decade. She founded Bina, a pioneering Bioinformatics company, out of a decade of research at Stanford and UC Berkeley. Bina developed high performance computing platforms and AI solutions for cancer research and genomics analysis. Later, upon acquisition of Bina by Roche, she led the clinical software development and AI research as VP of Informatics at Roche Sequencing until 2018.
-
Grant Barber
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Grant Barber is a Clinical Assistant Professor at Stanford University. His clinical passion is in the care of patients suffering from inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. After completing his medical training at Harvard Medical School, he completed his training in gastroenterology as well as a Master's degree in clinical research at Stanford. He completed additional training in advanced IBD management at Stanford before joining faculty. His research is focused on male reproductive health in IBD, quality improvement in the provision of IBD care, and economic studies to identify strategies that provide excellent outcomes while being sustainable within the healthcare system. He is an expert in tailoring evidence-based therapies to need of individual people with IBD.
-
Michele Barry, MD, FACP
Drs. Ben & A. Jess Shenson Professor, Senior Associate Dean, Global Health, Director, Center for Innovation in Global Health, Professor of Medicine, Senior Fellow at the Woods Institute and Professor, by courtesy, of Health Policy
Current Research and Scholarly InterestsAreas of research
Ethical Aspects of research conducted overseas
Clinical Tropical Diseases
Globalization's Impact upon Health Disparities
Human and Planetary Heath
Women Leadership -
Esther Bartl
Postdoctoral Fellow, Medicine - Primary Care and Population Health
Visiting Postdoctoral Scholar, Medicine - Primary Care and Population HealthBioI am a Postdoctoral Researcher in the lab of Pascal Geldsetzer affiliated with the Stanford University School of Medicine and the Heidelberg Institute of Global Health. My research examines questions at the intersection of health policy, epidemiology, and applied econometrics, with a focus on causal inference in large-scale health datasets.
